Physician-Supervised Weight Loss at VENUS MD
Medical weight loss in Orange County at VENUS MD provides a physician-supervised option for patients who have struggled to achieve or maintain meaningful weight reduction through diet and exercise alone. Medical weight loss provides another option for patients who have struggled to achieve or maintain meaningful weight reduction with diet and exercise alone.
At VENUS MD in Huntington Beach, Dr. Francois Bui provides individualized medical weight loss programs for patients throughout Orange County. Treatment may include semaglutide or tirzepatide when medically appropriate, together with physician evaluation, individualized dosing, and ongoing monitoring.
Semaglutide & Tirzepatide Weight Loss Programs
Personalized medical evaluation
Medical Weight Loss with Semaglutide & Tirzepatide
Semaglutide and tirzepatide are medications that act on hormonal pathways involved in appetite, satiety, and food intake.
Rather than relying on willpower alone, these medications can help appropriate patients feel satisfied with less food and make it easier to maintain the reduced caloric intake necessary for weight loss.
At VENUS MD, medication is one component of an individualized medical weight management plan. The appropriate medication, starting dose, dose progression, and treatment duration depend on the patient’s medical history, weight-loss goals, response, and tolerability.
Semaglutide for Weight Loss
Semaglutide is a GLP-1 receptor agonist. GLP-1 is a naturally occurring hormone involved in appetite regulation, satiety, digestion, and glucose metabolism.
By activating GLP-1 receptors, semaglutide can reduce appetite and increase the feeling of fullness after eating. For appropriate patients, this can make it easier to reduce food intake and maintain a calorie deficit.
Treatment generally begins at a lower dose and is adjusted gradually according to response and tolerability.
Semaglutide is not intended to replace healthy nutrition and physical activity. These remain important for achieving and maintaining weight-management goals.
Tirzepatide for Weight Loss
Tirzepatide works through two metabolic hormone pathways: GIP and GLP-1.
These pathways influence appetite, satiety, food intake, and glucose metabolism. For appropriate patients, tirzepatide can substantially reduce hunger and help patients feel satisfied after eating smaller amounts of food.
As with semaglutide, treatment generally begins at a lower dose and is adjusted over time according to the patient’s response and tolerability.
The medication selected should be based on the individual patient rather than assuming that one medication is appropriate for everyone.
Semaglutide vs. Tirzepatide: Which Is Right for Me?
Both semaglutide and tirzepatide can be used as part of medical weight management, but they are different medications.
Semaglutide acts primarily through the GLP-1 pathway.
Tirzepatide acts through both GIP and GLP-1 pathways.
The best choice depends on factors including medical history, previous weight-loss treatment, current medications, weight-loss goals, response to therapy, side effects, and individual preferences.
During consultation, Dr. Francois Bui evaluates these factors and discusses which approach may be appropriate.
How Medical Weight Loss Works at VENUS MD
Medical weight management begins with an evaluation rather than simply dispensing medication.
The initial assessment considers your current weight, weight history, previous attempts at weight loss, medical conditions, medications, treatment goals, and factors that may influence your ability to lose weight.
When semaglutide or tirzepatide is appropriate, treatment generally begins conservatively.
The dose may then be adjusted according to appetite response, weight change, tolerability, side effects, and the individualized treatment plan.
Progress is monitored over time so treatment can be adjusted rather than using the same dose or schedule for every patient.
How Much Weight Can I Lose?
Weight loss varies considerably between individuals.
Medication response, starting weight, nutrition, physical activity, treatment duration, dose, metabolic factors, and adherence can all influence the amount of weight lost.
For this reason, VENUS MD does not promise a specific number of pounds or percentage of body weight that every patient will lose.
The objective is meaningful, medically appropriate weight reduction together with habits that can support longer-term weight management.
Who May Be a Candidate for Medical Weight Loss?
Medical weight management may be considered for adults who have excess weight and have had difficulty achieving or maintaining adequate weight reduction through lifestyle changes alone.
Potential candidates may include patients who:
• Have struggled repeatedly with weight loss
• Experience persistent hunger or difficulty controlling appetite
• Regain weight after previous dieting
• Have weight-related health concerns
• Want physician-supervised treatment
• Are willing to make nutrition and lifestyle changes alongside medication
Medication is not appropriate for everyone. Medical history and other individual factors must be reviewed before treatment.
Side Effects & Medical Monitoring
Semaglutide and tirzepatide can cause side effects.
Common gastrointestinal effects may include nausea, decreased appetite, vomiting, diarrhea, constipation, abdominal discomfort, or indigestion. Side effects can vary according to the patient and dose.
More serious complications are possible, which is why medical history, current medications, symptoms, and treatment response should be reviewed as part of an appropriate medical weight-management program.
Patients should report significant or persistent symptoms rather than simply continuing or increasing medication without medical guidance.
Nutrition, Activity & Maintaining Weight Loss
Medication can make appetite control easier, but medication alone does not eliminate the importance of nutrition, activity, and long-term habits.
During weight loss, adequate protein intake and appropriate resistance exercise may be particularly important for helping preserve lean body mass.
Long-term weight management also requires planning for what happens after substantial weight has been lost.
The goal is therefore not simply to make the scale decrease as quickly as possible. Treatment should support an approach that the individual patient can realistically maintain.
Medical Weight Loss After Significant Weight Reduction
Patients who lose substantial amounts of weight may notice changes that medication cannot correct.
Loose abdominal skin, hanging upper-arm skin, changes in breast volume, or other areas of skin laxity may remain after weight loss.
For patients who reach a stable weight and are bothered by these changes, VENUS MD also provides surgical body-contouring options including tummy tuck and arm lift surgery.
Weight-loss treatment and body contouring address different problems and are evaluated separately according to the patient’s goals and anatomy.
Medical Weight Loss Pricing at VENUS MD
Medical weight loss programs are individualized according to the medication selected, dose, treatment plan, and required monitoring.
Semaglutide and tirzepatide options are available for appropriate patients.
Pricing and treatment options are reviewed during consultation.
Schedule a Medical Weight Loss Consultation in Orange County
Dr. Francois Bui provides medical weight management at VENUS MD in Huntington Beach for patients throughout Orange County.
Your consultation includes evaluation of your weight history, medical considerations, previous weight-loss efforts, treatment goals, and whether semaglutide, tirzepatide, or another approach is appropriate for you.
Medical Weight Loss Consultation | Call 714-839-8712
[/col]